SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-040024
Filing Date
2020-08-13
Accepted
2020-08-13 16:12:26
Documents
52
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rptx-10q_20200630.htm 10-Q 2348277
2 EX-10.1 rptx-ex101_64.htm EX-10.1 36341
3 EX-31.1 rptx-ex311_9.htm EX-31.1 18701
4 EX-31.2 rptx-ex312_8.htm EX-31.2 18704
5 EX-32.1 rptx-ex321_7.htm EX-32.1 8727
6 EX-32.2 rptx-ex322_6.htm EX-32.2 8743
  Complete submission text file 0001564590-20-040024.txt   5657792

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT rptx-20200630.xml EX-101.INS 814737
8 XBRL TAXONOMY EXTENSION SCHEMA rptx-20200630.xsd EX-101.SCH 39177
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rptx-20200630_cal.xml EX-101.CAL 37917
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rptx-20200630_def.xml EX-101.DEF 133626
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE rptx-20200630_lab.xml EX-101.LAB 314018
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rptx-20200630_pre.xml EX-101.PRE 243696
Mailing Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1
Business Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39335 | Film No.: 201099446
SIC: 2834 Pharmaceutical Preparations